Table 2.
Bivariate analysis of presented parameters in patients with COVID-19
| Parameters | Total Cholesterol | Triglyceride | HDL | Cholesterol | LDL Cholesterol | HbA1C | Glucose | AIP | Cholesterol to HDL |
|---|---|---|---|---|---|---|---|---|---|
| Total Cholesterol | r | 1 | 0.515 | 0.603* | 0.910** | -0.03 | -0.035 | 0.292 | 0.379 |
| P | 0.02 | 0.00 | |||||||
| Triglyceride | r | 1 | 0.036 | 0.319 | -0.04 | 0.339 | 0.880** | 0.416 | |
| P | 0.00 | ||||||||
| HDL-Cholesterol | r | 1 | 0.356 | -0.03 | -0.376 | -0.407 | -0.591 | ||
| P | |||||||||
| LDL- Cholesterol | r | 1 | -0.02 | 0.019 | 0.242 | 0.587 | |||
| P | |||||||||
| HbA1C | r | 1 | 0.994 | 0.6 | 0.51 | ||||
| P | 0.05 | ||||||||
| Glucose | r | 1 | 0.622 | 0.462 | |||||
| P | 0.05 | ||||||||
| AIP | r | 1 | 0.647* | ||||||
| P | 0.04 | ||||||||
| Cholesterol to HDL | r | 1 | |||||||
| P | |||||||||
There are significant differences between * and **